Sponsor pipeline

REGENXBIO Inc. clinical trial pipeline

Get alerts when REGENXBIO Inc.'s trials change

7 active trials 0 recruiting 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 2/3
2
Phase 3
1
Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07236606 RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome) MPS II Active, Not Recruiting 2026-06-04
Phase 2/3
NCT05693142 AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy… Duchenne Muscular Dystrophy Active, Not Recruiting 2026-07-21
NCT03566043 CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome) Mucopolysaccharidosis Type II (MPS II) Active, Not Recruiting 2025-01-28
Not specified
NCT04597385 Long-term Follow-Up for RGX-121 Mucopolysaccharidosis II Active, Not Recruiting 2026-08-19
NCT05683379 AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD Duchenne Muscular Dystrophy Active, Not Recruiting 2026-07-07
NCT06103487 Long Term Follow-Up for RGX-111 Mucopolysaccharidosis I Enrolling by Invitation 2026-04-29
NCT06491927 Long Term Follow-up for RGX-202 Duchenne Muscular Dystrophy Enrolling by Invitation 2026-03-24

Disease areas by active trials

Duchenne Muscular Dystrophy (3)

Get alerts when REGENXBIO Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free